Postoperative transient elevation of serum cancer antigen 125 in non-small cell lung cancer patients
SUMMARY OBJECTIVE: The aim of this retrospective study was to investigate the correlation of transiently elevated postoperative serum cancer antigen 125 levels and prognosis in patients with non-small cell lung cancer. METHODS: A total of 181 non-small cell lung cancer patients with normal levels of preoperative serum cancer antigen 125 were statistically summarized in this study. RESULTS: Out of the analyzed patients, 22 (12.2%) showed elevation of serum cancer antigen 125 within one month after surgery. Serum cancer antigen 125 level decreased to normal at three months postoperation. Serum cancer antigen 125 was positively correlated with pro-brain natriuretic peptide in non-small cell lung cancer postoperative patients (p=0.00035). Univariate analysis did not find significant difference in disease progression survival between those who experienced cancer antigen 125 elevation in the early postoperation and those who did not (p=0.646). CONCLUSIONS: In conclusion, transient elevation of cancer antigen 125 is associated to pro-brain natriuretic peptide increase after pulmonary surgery in non-small cell lung cancer patients.
Main Author: | |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Associação Médica Brasileira
2021
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000100039 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0104-42302021000100039 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0104-423020210001000392021-06-16Postoperative transient elevation of serum cancer antigen 125 in non-small cell lung cancer patientsYe,Yiwang Carcinoma, non-small-cell lung CA-125 antigens Biomarkers Neoplasms Natriuretic peptide, brain SUMMARY OBJECTIVE: The aim of this retrospective study was to investigate the correlation of transiently elevated postoperative serum cancer antigen 125 levels and prognosis in patients with non-small cell lung cancer. METHODS: A total of 181 non-small cell lung cancer patients with normal levels of preoperative serum cancer antigen 125 were statistically summarized in this study. RESULTS: Out of the analyzed patients, 22 (12.2%) showed elevation of serum cancer antigen 125 within one month after surgery. Serum cancer antigen 125 level decreased to normal at three months postoperation. Serum cancer antigen 125 was positively correlated with pro-brain natriuretic peptide in non-small cell lung cancer postoperative patients (p=0.00035). Univariate analysis did not find significant difference in disease progression survival between those who experienced cancer antigen 125 elevation in the early postoperation and those who did not (p=0.646). CONCLUSIONS: In conclusion, transient elevation of cancer antigen 125 is associated to pro-brain natriuretic peptide increase after pulmonary surgery in non-small cell lung cancer patients.info:eu-repo/semantics/openAccessAssociação Médica BrasileiraRevista da Associação Médica Brasileira v.67 n.1 20212021-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000100039en10.1590/1806-9282.67.01.20200102 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Ye,Yiwang |
spellingShingle |
Ye,Yiwang Postoperative transient elevation of serum cancer antigen 125 in non-small cell lung cancer patients |
author_facet |
Ye,Yiwang |
author_sort |
Ye,Yiwang |
title |
Postoperative transient elevation of serum cancer antigen 125 in non-small cell lung cancer patients |
title_short |
Postoperative transient elevation of serum cancer antigen 125 in non-small cell lung cancer patients |
title_full |
Postoperative transient elevation of serum cancer antigen 125 in non-small cell lung cancer patients |
title_fullStr |
Postoperative transient elevation of serum cancer antigen 125 in non-small cell lung cancer patients |
title_full_unstemmed |
Postoperative transient elevation of serum cancer antigen 125 in non-small cell lung cancer patients |
title_sort |
postoperative transient elevation of serum cancer antigen 125 in non-small cell lung cancer patients |
description |
SUMMARY OBJECTIVE: The aim of this retrospective study was to investigate the correlation of transiently elevated postoperative serum cancer antigen 125 levels and prognosis in patients with non-small cell lung cancer. METHODS: A total of 181 non-small cell lung cancer patients with normal levels of preoperative serum cancer antigen 125 were statistically summarized in this study. RESULTS: Out of the analyzed patients, 22 (12.2%) showed elevation of serum cancer antigen 125 within one month after surgery. Serum cancer antigen 125 level decreased to normal at three months postoperation. Serum cancer antigen 125 was positively correlated with pro-brain natriuretic peptide in non-small cell lung cancer postoperative patients (p=0.00035). Univariate analysis did not find significant difference in disease progression survival between those who experienced cancer antigen 125 elevation in the early postoperation and those who did not (p=0.646). CONCLUSIONS: In conclusion, transient elevation of cancer antigen 125 is associated to pro-brain natriuretic peptide increase after pulmonary surgery in non-small cell lung cancer patients. |
publisher |
Associação Médica Brasileira |
publishDate |
2021 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000100039 |
work_keys_str_mv |
AT yeyiwang postoperativetransientelevationofserumcancerantigen125innonsmallcelllungcancerpatients |
_version_ |
1756410101048016896 |